HERCULES PHARMACEUTICALS
Hercules is a biopharmaceutical company developing an innovative, oral, non-toxic drug therapy for chronic treatment of patients with Triple Negative Breast Cancer, and other solid tumors. The company has demonstrated that blocking the Aryl hydrocarbon Receptor in solid tumors could: Enhance the response of the immune system to cancer Reduce the chance of future relapses by reducing the number of Cancer Stem Cells Reduce metastatic behavior Reduce agression of existing cancer Make cancer cells more sensitive to standard chemotherapy Hercules have discovered novel anti-cancer drugs that block the Aryl Hydrocarbon receptor and is now testing these products in preparation for clinical trials.
HERCULES PHARMACEUTICALS
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
2013-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.hercules-pharma.nl
Total Employee:
11+
Status:
Active
Contact:
+31 (0)346745139
Email Addresses:
[email protected]
Total Funding:
300 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Euro
Current Employees Featured
Founder
Investors List
UNIIQ
UNIIQ investment in Seed Round - Hercules Pharmaceuticals
Official Site Inspections
http://www.hercules-pharma.nl
- Host name: shared3.inforitus.nl
- IP address: 213.132.223.120
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Hercules Pharmaceuticals"
Hercules Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number +31 (0)346745139 Hercules is a biopharmaceutical company developing an innovative, oral, non …See details»
Hercules Pharmaceuticals B.V. - IFG
Hercules is a biopharmaceutical company developing an innovative, oral, non-toxic drug therapy for chronic treatment of patients with Triple Negative Breast Cancer, and other solid tumors. …See details»
Hercules Pharmaceuticals BV - Drug pipelines, Patents, Clinical …
Explore Hercules Pharmaceuticals BV with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Infectious Diseases, Technology Platform:Small ...See details»
Hercules Pharmaceuticals B.V. - IFG
Hercules is een biofarmaceutisch bedrijf dat innovatieve, orale, niet-toxische medicamenteuze therapieën ontwikkelt voor de behandeling van patiënten met kanker alsmede voor de …See details»
Hercules Pharmaceuticals - Products, Competitors, Financials, …
Aug 20, 2020 Hercules Pharmaceuticals focuses on developing innovative oral drug therapies in the pharmaceutical industry, specifically targeting cancer and viral infections by inhibiting the …See details»
Hercules Pharmaceuticals | VentureRadar
Similar Companies: Avalo Therapeutics USA Publicly Traded Avalo is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, …See details»
Hercules' AhR inhibitor HP163 blocks viral replication in Zika ...
Aug 20, 2020 www.hercules-pharma.nl. LifeSpring Life Sciences Communication, Amsterdam, the Netherlands Leon Melens T: +31-6-538-16-427 E: [email protected] SOURCE Hercules …See details»
Hercules Pharma - CoBee Company Profile & Funding Rounds
Hercules Pharma. Hercules is a healthcare industry developing a novel way of treatment for patients with triple negative breast cancer. Business Model: Revenue: $1. Employees: 1-1. ...See details»
Pharma Connect Capital invests in Hercules Pharmaceuticals B.V.
The fund is an initiative of Investerings Fonds Groningen, University Medical Center Groningen and the Noordelijke Ontwikkelings Maatschappij (NOM) and was launched in October 2017. …See details»
Hercules’ AhR inhibitor HP163 blocks viral replication in Zika ...
Aug 21, 2020 Leiden, The Netherlands, August 20, 2020 – Hercules Pharmaceuticals, a Dutch biopharmaceutical company focusing on developing small molecule inhibitors of the Aryl …See details»
Full List of Pharmaceutical Companies in the …
Nov 5, 2022 The Association of Innovative Medicines is an association of more than 40 pharmaceutical companies in the Netherlands, both local and multinational pharma companies. Pharmaceutical Companies in the …See details»
EMERGING COMPANY PROFILE HERCULES’ IDO ALTERNATIVE
HERCULES’ IDO ALTERNATIVE BY STEPHEN HANSEN, ASSOCIATE EDITOR Hercules Pharmaceuticals B.V. is developing an inhibitor of aryl hydrocarbon receptor that taps into the …See details»
Hercules' AhR inhibitor HP163 blocks viral replication in Zika ...
LEIDEN, Netherlands, Aug. 20, 2020 /PRNewswire/ -- Hercules Pharmaceuticals, a Dutch biopharmaceutical company focusing on developing small molecu...See details»
Hercules' AhR Inhibitor HP163 Blocks Viral Replication in Zika ...
Aug 20, 2020 Secured additional funding for Covid-19 testing and back-up drug discovery. LEIDEN, The Netherlands, August 20, 2020 / B3C newswire / --Hercules Pharmaceuticals, a …See details»
Hercules Pharmaceuticals receives investment from UNIIQ for the ...
Title: Microsoft Word - Hercules Pharmaceuticals receives investment from UNIIQ for the development of cancer immunotherapy.docx Created Date: 8/25/2017 9:03:10 AMSee details»
Hercules Pharma ®️ (@hercules.pharma) - Instagram
3,462 Followers, 43 Following, 39 Posts - Hercules Pharma ®️ (@hercules.pharma) on Instagram: "ÚNICO PERFIL OFICIAL HP O melhor do Brasil QUALIDADE HONESTIDADE …See details»
Hercules - Your Site Title
Hercules is a fully independent pharmaceutical wholesale distributor accredited and licensed by the National Association of Boards of Pharmacy (NABP) in all 50 states. As a leading supplier …See details»
60亿美元，恒瑞医药GLP-1产品组合授权出海医药新闻-ByDrug-一 …
May 17, 2024 了解企业： Hercules Pharmaceuticals 了解药品： GLP-1 近日，包括贝恩资本生命科学公司、RTW Investments、Atlas Venture 和 Lyra Capital 在内的投资机构向本月成立的 …See details»
Alveron Pharma Announces Close of €5M Seed Extension …
1 day ago NIJMEGEN, Netherlands–(BUSINESS WIRE)–#AlveronPharma—Alveron Pharma is pleased to announce today the closing of a €5.0 million Series Seed extension financing …See details»
60亿美元：恒瑞医药GLP-1产品组合授权给Hercules - 雪球
May 16, 2024 Hercules是一家今年5月刚刚成立的公司，由贝恩资本... 60亿美元：恒瑞医药GLP-1产品组合授权给Hercules Armstrong 2024年5月16日， 恒瑞医药 发布公告，将GLP-1产品组 …See details»